Loading viewer...
investor_presentation
Format: PDF investor_presentation
Nova Eye Medical presents its strategic initiatives to address glaucoma and age-related macular degeneration (AMD), the leading causes of blindness. The company details its canaloplasty surgical devices portfolio, 2RT technology for intermediate AMD, established US and international sales infrastructure, and regulatory clearances across major markets including FDA approval.
investor_presentation
105 Pages
Avalara
investor_presentation
Sartorius Group
investor_presentation
Lithium Africa
investor_presentation
Leonteq